UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Low-Abundance Drug-Resistant Viral Variants in Chronically HIV-Infected, Antiretroviral Treatment–Naive Patients Significantly Impact Treatment Outcomes

The Journal of infectious diseases, 2009-03, Vol.199 (5), p.693-701

2009

Volltextzugriff (PDF)

Instantaneous Inhibitory Potential and Inhibitory Quotient Show a Modest Association with Virologic Outcome: Is Either a Useful Surrogate for Clinical Drug Efficacy?

Clinical infectious diseases, 2010-07, Vol.51 (1), p.99-100

MacArthur, Rodger D.

2010

Volltextzugriff (PDF)

Antiretroviral medication adherence and class-specific resistance in a large prospective clinical trial

AIDS (London), 2010-01, Vol.24 (3), p.395-403

2010

Volltextzugriff (PDF)

Maraviroc: The First of a New Class of Antiretroviral Agents

Clinical infectious diseases, 2008-07, Vol.47 (2), p.236-241

2008

Volltextzugriff (PDF)

Impact of Climate Change on Cellulitis: A Literature Review

Curēus (Palo Alto, CA), 2024-07

2024

Volltextzugriff (PDF)

Etiology and Pharmacologic Management of Noninfectious Diarrhea in HIV-Infected Individuals in the Highly Active Antiretroviral Therapy Era

Clinical infectious diseases, 2012-09, Vol.55 (6), p.860-867

2012

Volltextzugriff (PDF)

CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection

AIDS (London), 2008-04, Vol.22 (7), p.841-848

2008

Volltextzugriff (PDF)

Management of noninfectious diarrhea associated with HIV and highly active antiretroviral therapy

The American journal of managed care, 2013-09, Vol.19 (12 Suppl), p.s238-s245

Macarthur, Rodger D

2013

Volltextzugriff (PDF)

Profile of etravirine for the treatment of HIV infection

Therapeutics and clinical risk management, 2010-01, Vol.6 (default), p.49-58

2010

Volltextzugriff (PDF)

Asymptomatic SARS-CoV-2 Infection Is Common Among ART-Treated People With HIV

Journal of acquired immune deficiency syndromes (1999), 2022-08, Vol.90 (4), p.377-381

2022

Volltextzugriff (PDF)

Infectious Diseases Physicians: Improving and Protecting the Public's Health: Why Equitable Compensation Is Critical

Clinical infectious diseases, 2019-07, Vol.69 (2), p.352-356

2019

Volltextzugriff (PDF)

Reviews of anti-infective agents: maraviroc: the first of a new class of antiretroviral agents

Clinical infectious diseases, 2008-07, Vol.47 (2), p.236-241

2008

Volltextzugriff (PDF)

New antiretroviral drugs: a review of the efficacy, safety, pharmacokinetics, and resistance profile of tipranavir, darunavir, etravirine, rilpivirine, maraviroc, and raltegravir

Expert opinion on pharmacotherapy, 2009-10, Vol.10 (15), p.2445-2466

2009

Volltextzugriff (PDF)

Poor initial CD4+ recovery with antiretroviral therapy prolongs immune depletion and increases risk for AIDS and non-AIDS diseases

Journal of acquired immune deficiency syndromes (1999), 2008-08, Vol.48 (5), p.541-546

2008

Volltextzugriff (PDF)

Abacavir/lamivudine combination in the treatment of HIV: a review

Therapeutics and clinical risk management, 2010-01, Vol.6 (default), p.83-94

2010

Volltextzugriff (PDF)

Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab′)2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels

Critical care medicine, 2004-11, Vol.32 (11), p.2173-2182

2004

Volltextzugriff (PDF)

Adequacy of Early Empiric Antibiotic Treatment and Survival in Severe Sepsis: Experience from the MONARCS Trial

Clinical infectious diseases, 2004-01, Vol.38 (2), p.284-288

2004

Volltextzugriff (PDF)

Discordance between Viral Loads Determined by Roche COBAS AMPLICOR Human Immunodeficiency Virus Type 1 Monitor (Version 1.5) Standard and Ultrasensitive Assays Caused by Freezing Patient Plasma in Centrifuged Becton-Dickinson Vacutainer Brand Plasma Preparation Tubes

Journal of Clinical Microbiology, 2005-09, Vol.43 (9), p.4635-4639

2005

Volltextzugriff (PDF)

A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CPCRA 058 FIRST Study): a long-term randomised trial

The Lancet (British edition), 2006-12, Vol.368 (9553), p.2125-2135

2006

Volltextzugriff (PDF)

Widely Disseminated Cryptococcosis Manifesting in a Previously Undiagnosed Human Immunodeficiency Virus (HIV)-Positive 18-Year-Old

The American journal of case reports, 2020-10, Vol.21, p.e924410-e924410

2020

Volltextzugriff (PDF)

Differential adherence to combination antiretroviral therapy is associated with virological failure with resistance

AIDS (London), 2008-01, Vol.22 (1), p.75-82

2008

Volltextzugriff (PDF)

Adapting Education at the Medical College of Georgia at Augusta University in Response to the COVID-19 Pandemic: the Pandemic Medicine Elective

Medical science educator, 2021-04, Vol.31 (2), p.843-850

2021

Volltextzugriff (PDF)

Crofelemer, a novel agent for treatment of non-infectious diarrhea in HIV-infected persons

Expert review of gastroenterology & hepatology, 2013-09, Vol.7 (7), p.591-600

2013

Volltextzugriff (PDF)

Overview of the XIX International AIDS Conference

Current infectious disease reports, 2013-02, Vol.15 (1), p.1-3

MacArthur, Rodger D.

2013

Volltextzugriff (PDF)

1 – 25 von 96

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(67)

Publikationsform

Sprache

Englisch
(96)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Low-Abundance Drug-Resistant Viral Variants in Chronically HIV-Infected, Antiretroviral Treatment–Naive Patients Significantly Impact Treatment Outcomes

Instantaneous Inhibitory Potential and Inhibitory Quotient Show a Modest Association with Virologic Outcome: Is Either a Useful Surrogate for Clinical Drug Efficacy?

Antiretroviral medication adherence and class-specific resistance in a large prospective clinical trial

Maraviroc: The First of a New Class of Antiretroviral Agents

Impact of Climate Change on Cellulitis: A Literature Review

Etiology and Pharmacologic Management of Noninfectious Diarrhea in HIV-Infected Individuals in the Highly Active Antiretroviral Therapy Era

CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection

Management of noninfectious diarrhea associated with HIV and highly active antiretroviral therapy

Profile of etravirine for the treatment of HIV infection

Asymptomatic SARS-CoV-2 Infection Is Common Among ART-Treated People With HIV

Infectious Diseases Physicians: Improving and Protecting the Public's Health: Why Equitable Compensation Is Critical

Reviews of anti-infective agents: maraviroc: the first of a new class of antiretroviral agents

New antiretroviral drugs: a review of the efficacy, safety, pharmacokinetics, and resistance profile of tipranavir, darunavir, etravirine, rilpivirine, maraviroc, and raltegravir

Poor initial CD4+ recovery with antiretroviral therapy prolongs immune depletion and increases risk for AIDS and non-AIDS diseases

Abacavir/lamivudine combination in the treatment of HIV: a review

Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab′)2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels

Adequacy of Early Empiric Antibiotic Treatment and Survival in Severe Sepsis: Experience from the MONARCS Trial

Discordance between Viral Loads Determined by Roche COBAS AMPLICOR Human Immunodeficiency Virus Type 1 Monitor (Version 1.5) Standard and Ultrasensitive Assays Caused by Freezing Patient Plasma in Centrifuged Becton-Dickinson Vacutainer Brand Plasma Preparation Tubes

A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CPCRA 058 FIRST Study): a long-term randomised trial

Widely Disseminated Cryptococcosis Manifesting in a Previously Undiagnosed Human Immunodeficiency Virus (HIV)-Positive 18-Year-Old

Differential adherence to combination antiretroviral therapy is associated with virological failure with resistance

Adapting Education at the Medical College of Georgia at Augusta University in Response to the COVID-19 Pandemic: the Pandemic Medicine Elective

Nonnucleoside Reverse-transcriptase Inhibitor- vs Ritonavir-boosted Protease Inhibitor–based Regimens for Initial Treatment of HIV Infection: A Systematic Review and Metaanalysis of Randomized Trials

Crofelemer, a novel agent for treatment of non-infectious diarrhea in HIV-infected persons

Overview of the XIX International AIDS Conference

Suchergebnisse filtern